A tablet formulated with cannabidiol, or CBD, reduces pain after shoulder surgery, with no safety concerns, a study presented Friday during the American Academy of Orthopaedic Surgeons meeting found.

The tablet, called Oravexx, developed by New Jersey-based life sciences firm Orcosa, contains 50 milligrams of CBD and safely managed pain after minimally invasive rotator-cuff surgery, the data showed. In addition, treatment with Oravexx did not produce any of the side effects associated with CBD use, such as nausea, anxiety and liver problems.